ライフサイエンスコーパス: polymerase chain reaction

1 RT-qPCR (quantitative reverse transcription polymerase chain reaction).

2 ence, and quantitative reverse transcription polymerase chain reaction.

3 nd var gene transcription using quantitative polymerase chain reaction.

4 e-linked immunosorbent assay, and CMV DNA by polymerase chain reaction.

5 type markers was investigated with real-time polymerase chain reaction.

6 measured by flow cytometry and quantitative polymerase chain reaction.

7 ed nucleic acid-based quantitative real-time polymerase chain reaction.

8 tion were analyzed by real-time quantitative polymerase chain reaction.

9 , transcriptional analyses, and quantitative polymerase chain reaction.

10 re, direct immunofluorescence assay (DFA) or polymerase chain reaction.

11 s and receptors was measured using real-time polymerase chain reaction.

12 tion, and quantitative reverse transcription polymerase chain reaction.

13 re investigated by immunoassay and real-time polymerase chain reaction.

14 al methanogens were measured by quantitative polymerase chain reaction.

15 ined with quantitative reverse-transcription polymerase chain reaction.

16 ed for RV by real-time reverse-transcription polymerase chain reaction.

17 pesviruses (HHVs) were measured by real-time polymerase chain reaction.

18 RNA genes were quantified using quantitative polymerase chain reaction.

19 yzed by 16S rRNA sequencing and quantitative polymerase chain reaction.

20 imated by quantitative reverse transcription-polymerase chain reaction.

21 und using reverse transcription-quantitative polymerase chain reaction.

22 ection by reverse transcription quantitative polymerase chain reaction.

23 hroughput reverse transcription quantitative polymerase chain reaction.

24 cific oligonucleotide real-time quantitative polymerase chain reaction.

25 issues by reverse transcriptase-quantitative polymerase chain reaction.

26 LTL was measured by quantitative polymerase chain reaction.

27 after the infusion by quantitative real-time polymerase chain reaction.

28 rified by quantitative reverse transcriptase polymerase chain reaction.

29 histologically and by reverse transcription polymerase chain reaction.

30 n was determined with quantitative real-time polymerase chain reaction.

31 zed using Gut Low-Density Array quantitative polymerase chain reaction.

32 sured with the use of quantitative real-time polymerase chain reaction.

33 virus by quantitative reverse-transcription polymerase chain reaction.

34 nza virus by real-time reverse-transcription polymerase chain reaction.

35 9 years admitted with influenza confirmed by polymerase chain reaction.

36 munohistochemistry, histology, and real-time polymerase chain reaction.

37 in tumor tissue, determined by quantitative polymerase chain reaction.

38 or HBoV mRNA and genomic DNA by quantitative polymerase chain reaction.

39 monitored for ocular chlamydial infection by polymerase chain reaction.

40 ssed by zymography and reverse-transcription polymerase chain reaction.

41 s were analyzed using real-time quantitative polymerase chain reaction.

42 specific nucleic acid molecules amplified by polymerase chain reactions.

43 In the 3 decades since the discovery of the polymerase chain reaction, a progression of remarkable t

44 hese substrates were efficiently prepared by polymerase chain reaction amplification followed by site

45 ization of Giardia isolates was performed by polymerase chain reaction amplification of a fragment of

46 efforts to identify gametocyte carriers use polymerase chain reaction amplification of the gametocyt

47 ymphocytes and CLN3 transcript analysis with polymerase chain reaction amplification were performed i

48 ssembly (TPA), which is a method to assemble polymerase chain reaction-amplified fragments into a pla

49 d chromatin immunoprecipitation quantitative polymerase chain reaction analyses in Huh-7 cells.

50 We performed reverse transcription polymerase chain reaction analyses of 102 non-small cell

51 Quantitative polymerase chain reaction analyses of CB1190 abundance,

52 real-time reverse-transcription quantitative polymerase chain reaction analyses of rectal RNA from an

53 We performed quantitative polymerase chain reaction analyses of the expression of

54 Immunohistochemical and quantitative polymerase chain reaction analyses show expression of th

55 We used immunohistochemical and quantitative polymerase chain reaction analyses to examine expression

56 mass spectrometry and quantitative real-time polymerase chain reaction analyses to quantify DNA methy

57 eriacieae (CRE) isolates were evaluated with polymerase chain reaction analysis for carbapenemase gen

58 MRD was evaluated by polymerase chain reaction analysis of Ig/TCR gene rearra

59 ion density was calculated with quantitative polymerase chain reaction analysis of nasopharyngeal/oro

60 for Plasmodium falciparum, using an RDT and polymerase chain reaction analysis, and were followed un

61 Isolates were tested by real-time polymerase chain reaction analysis, slide agglutination,

62 samples were analyzed using semiquantitative polymerase chain reaction analysis.

63 ratory validation by standard and long-range polymerase chain reaction and amplicon resequencing with

64 r ZIKV using real-time reverse-transcriptase-polymerase chain reaction and an IgM antibody-capture en

65 d cytokine expression levels by quantitative polymerase chain reaction and flow cytometry.

66 Reverse-transcriptase polymerase chain reaction and immunoblot analysis were u

67 n expression were analyzed with quantitative polymerase chain reaction and immunoblotting, respective

68 We performed quantitative polymerase chain reaction and immunofluorescence analyse

69 t's collecting duct cells using quantitative polymerase chain reaction and immunohistochemical staini

70 Reverse transcription polymerase chain reaction and immunohistochemistry subse

71 this locus by coupling reverse transcription polymerase chain reaction and long-read sequencing.

72 stem-loop reverse-transcriptase quantitative polymerase chain reaction and mRNA microarray, respectiv

73 16S rRNA genes was measured by Quantitative Polymerase Chain Reaction and no apparent differences we

74 ding mutations, can be derived using digital polymerase chain reaction and other technologies.

75 analyzed by immunohistochemical quantitative polymerase chain reaction and sphingosine kinase activit

76 Reverse transcription polymerase chain reaction and transcriptome analyses sug

77 d miR-132, which were confirmed by real-time polymerase chain reaction and were significantly higher

78 uration and ionic currents, and quantitative polymerase chain reaction and Western blotting to invest

79 Real-time polymerase chain reaction and Western blotting were used

80 Y1 copy number (genotyped by digital droplet polymerase chain reaction) and obesity traits in 4800 in

81 cantly upregulated at the gene (quantitative polymerase chain reaction) and protein (enzymatic activi

82 erial burden (determined by 16S quantitative polymerase chain reaction), and specific microbial opera

83 blotting, quantitative reverse-transcription polymerase chain reaction, and cell death assays.

84 tified by quantitative reverse transcriptase-polymerase chain reaction, and DNA methylation was quant

85 using flow cytometry, reverse-transcription polymerase chain reaction, and enzyme-linked immunoassay

86 chemical, quantitative reverse transcription polymerase chain reaction, and flow cytometry analyses.

87 stochemistry, luciferase activity, real-time polymerase chain reaction, and multiplex assays.

88 is, pulsed-field gel electrophoresis (PFGE), polymerase chain reaction, and pertactin gene sequencing

89 ning, flow cytometry, quantitative real-time polymerase chain reaction, and reciprocal bone marrow tr

90 tested with real-time reverse-transcription polymerase chain reaction, and virus culture and isolate

91 y; gene expression was examined by real-time polymerase chain reaction; and data from The Cancer Geno

92 Reverse-transcription quantitative polymerase chain reaction array profiling was used to id

93 real-time reverse-transcription quantitative polymerase chain reaction array to analyze messenger RNA

94 METHODS AND Using a quantitative polymerase chain reaction array, we found that histone m

95 E for studies evaluating these tests against polymerase chain reaction as the reference standard.

96 ng, and highly sensitive and allele-specific polymerase chain reaction (AS-PCR) assays that we develo

97 ript in a quantitative reverse transcriptase polymerase chain reaction assay confirmed by a second an

98 A quantitative real-time polymerase chain reaction assay of US17, which correlate

99 V-D68 using real-time reverse- transcription polymerase chain reaction assay.

100 g, fluorescent microsphere, and quantitative polymerase chain reaction assays at loci associated with

101 Quantitative reverse-transcription polymerase chain reaction assays were developed to quant

102 aire Target 1, major groove binder real-time-polymerase chain reaction assays, and original Xpert EBO

103 As to be quantified in reverse transcription/polymerase chain reaction assays.

104 these questions, we developed a quantitative polymerase chain reaction-based approach to determine th

105 f p57 expression by immunohistochemistry and polymerase chain reaction-based DNA genotyping have emer

106 Here we introduce a quantitative real time polymerase chain reaction-based environmental DNA (eDNA)

107 Using genomic sequence data and polymerase chain reaction-based genotyping, we identifie

108 ssessment techniques, like flow cytometry or polymerase chain reaction-based methods, has been challe

109 A polymerase chain reaction-based miRNA array of plasma, s

110 Polymerase chain reaction-based selective miRNA analysis

111 um/plasma samples from reverse-transcription polymerase chain reaction-confirmed cases including 20 p

112 za infection (SDI) and reverse-transcription polymerase chain reaction-confirmed influenza illness (P

113 Of the 112 with polymerase chain reaction-confirmed Zika virus infection

114 ngs in a cohort of infants whose mothers had polymerase chain reaction-confirmed Zika virus infection

115 The cure rate (ie, polymerase chain reaction-corrected adequate clinical an

116 previously reported a novel droplet digital polymerase chain reaction (ddPCR) assay targeting the mi

117 ining DNase I digestion and CMV quantitative polymerase chain reaction (DNase-CMV-qPCR) was developed

118 Digital polymerase chain reaction (dPCR) end point platforms dir

119 was determined using real-time quantitative polymerase chain reaction, dual-labeling immunofluoresce

120 Real-time polymerase chain reaction, (far) Western blot, immunopre

121 ession-by quantitative reverse transcription polymerase chain reaction, flow cytometry, and Western b

122 A microarray analysis, reverse transcription polymerase chain reaction, fluorescent in situ hybridiza

123 groups by semiquantitative and quantitative polymerase chain reaction followed by immunoblotting and

124 ocytes and single-cell reverse transcription polymerase chain reaction followed by reexpression, whic

125 and vaginal swab specimens were evaluated by polymerase chain reaction followed by type-specific hybr

126 nia were tested using quantitative real-time polymerase chain reaction for 17 viruses.

127 follow-up stools were tested by quantitative polymerase chain reaction for 32 enteropathogens with th

128 maxillary molars were subjected to real-time polymerase chain reaction for assessment of osteoprotegr

129 ative stress, inflammation (IL-8), real-time polymerase chain reaction for epithelial-to-mesenchymal

130 In a subgroup, polymerase chain reaction for HEV was performed.

131 We performed quantitative polymerase chain reaction for multiple enteropathogens o

132 uid, or placenta samples tested by real-time polymerase chain reaction for Zika virus.

133 alth authorities and confirmed by culture or polymerase chain reaction from July 1996 to December 201

134 d to rely on real-time reverse transcription polymerase chain reaction from respiratory samples, vari

135 IL-6) by quantitative reverse transcription polymerase chain reaction, IL-6 immunostaining, activati

136 tion of JCV from the tissues by quantitative polymerase chain reaction illuminated sites of viral per

137 ractility measurement, reverse-transcription polymerase chain reaction, immunoblot, immunohistochemis

138 models by quantitative reverse transcriptase-polymerase chain reaction, immunoblotting, and immunoflu

139 used for quantitative reverse-transcriptase polymerase chain reaction, immunocytochemistry, and conf

140 performed quantitative reverse transcription polymerase chain reaction, immunofluorescence, and immun

141 were collected and analyzed by quantitative polymerase chain reaction, immunohistochemistry, and flo

142 valuated cases of RSV and HRV codetection by polymerase chain reaction in 2 prospective birth cohort

143 by using quantitative reverse transcriptase-polymerase chain reaction in 350 subjects from the same

144 METHODS AND We measured LTL by quantitative polymerase chain reaction in 566 outpatients (age: 63+/-

145 idated by reverse-transcriptase quantitative polymerase chain reaction in an independent cohort of 71

146 antitated by real-time reverse transcription-polymerase chain reaction in C cases presenting between

147 asured by reverse-transcription quantitative polymerase chain reaction in healthy controls (n = 10) a

148 were quantified using quantitative real-time polymerase chain reaction in human postmortem dorsolater

149 We further applied quantitative real-time polymerase chain reaction in independent samples for val

150 , and varicella zoster virus (VZV) by weekly polymerase chain reaction in plasma.

151 We compared xenodiagnosis with quantitative polymerase chain reaction in skin biopsies from 3 patien

152 deaminase activity that eliminates potential polymerase chain reaction-induced biases.

153 rporate nucleic acid-based assays, including polymerase chain reaction, isothermal amplification, lig

154 Quantitative polymerase chain reaction JCPyV was used prospectively a

155 aterials are often based on species-specific polymerase chain reaction, limited to detecting species

156 nin antibody titers, and by genetic testing (polymerase chain reaction/loop-mediated isothermal ampli

157 The median time of reverse-transcription polymerase chain reaction negativity was 46.4 days after

158 l samples using Nested-Reverse Transcription Polymerase Chain Reaction (nRT-PCR).

159 alysis by quantitative reverse transcription polymerase chain reaction of extracellular purine degrad

160 ion was assessed by using Cre-reporter mice, polymerase chain reaction of genomic DNA, and quantitati

161 alyzed by reverse transcription quantitative polymerase chain reaction or confocal microscopy.

162 aining patients, using reverse transcriptase polymerase chain reaction or transcriptome sequencing, w

163 arison with a published reverse transciptase-polymerase chain reaction panel.

164 -rich protein 2-based RDTs using qualitative polymerase chain reaction (PCR) (nested PCR targeting th

165 and clinical impact of a targeted panfungal polymerase chain reaction (PCR) amplicon sequencing assa

166 ochondrial lysates without DNA extraction or polymerase chain reaction (PCR) amplification in just 75

167 During polymerase chain reaction (PCR) amplification, selective

168 ntitative cytomegalovirus (CMV) DNA-specific polymerase chain reaction (PCR) analysis is widely used

169 in the human central nervous system (CNS) by polymerase chain reaction (PCR) analysis, but tissue loc

170 chinella serology on patient sera as well as polymerase chain reaction (PCR) and larval identificatio

171 Polymerase chain reaction (PCR) and other molecular assa

172 Quantitative polymerase chain reaction (PCR) and reverse-transcriptio

173 ntimicrobial resistance (AMR), with targeted polymerase chain reaction (PCR) approaches increasingly

174 disease (CCD), as well as the usefulness of polymerase chain reaction (PCR) as a tool to predict the

175 o diagnose Acanthamoeba keratitis (AK) using polymerase chain reaction (PCR) as the reference diagnos

176 nsplant monitoring by quantitative real-time polymerase chain reaction (PCR) assay.

177 and tested for bacteria, using quantitative polymerase chain reaction (PCR) assays targeting the 16S

178 lar probing technologies involving real-time polymerase chain reaction (PCR) assays that facilitate d

179 ZIKV-RNA load was quantified by polymerase chain reaction (PCR) cycles in blood/ urine.

180 Detection of pneumococcus by lytA polymerase chain reaction (PCR) in blood had poor diagno

181 erial pathogen detection by both culture and polymerase chain reaction (PCR) in children.

182 nsecutive newborns were screened for cCMV by polymerase chain reaction (PCR) in saliva.

183 Overlapping polymerase chain reaction (PCR) is a common technique us

184 virus (hCMV) in cerebrospinal fluid (CSF) by polymerase chain reaction (PCR) is a marker of central n

185 Long-range polymerase chain reaction (PCR) is a traditional approac

186 Polymerase chain reaction (PCR) is dependent on two key

187 smodium species were identified using nested polymerase chain reaction (PCR) of ribosomal RNA genes a

188 ally based on technologies such as real-time polymerase chain reaction (PCR) or DNA sequencing, which

189 ivors, declared cured after 2 negative blood polymerase chain reaction (PCR) results, face psychosoci

190 Routine polymerase chain reaction (PCR) ribotyping and multiple-

191 nvestigated in 1 index sample using specific polymerase chain reaction (PCR) sequencing and culture.

192 spleen was not palpable, and a quantitative polymerase chain reaction (PCR) test for JAK2/V617F was

193 Polymerase chain reaction (PCR) testing of aqueous or vi

194 Case status was established most commonly by polymerase chain reaction (PCR) testing of blood and les

195 This approach requires extensive polymerase chain reaction (PCR) testing of the Wolbachia

196 aryngeal aspirate samples were analyzed with polymerase chain reaction (PCR) tests for HMPV, RSV, and

197 scopy (SERS) in combination with multiplexed polymerase chain reaction (PCR) was utilized to detect m

198 Rapid diagnostic test (RDT), microscopy, and polymerase chain reaction (PCR) were used to detect asym

199 RNA sequencing (RNA-seq) and real-time polymerase chain reaction (PCR) were used to examine tra

200 lementation of DNA amplification through the Polymerase Chain Reaction (PCR) with thermal cycling amo

201 of the 6-month dry season were identified by polymerase chain reaction (PCR), and clinical malaria ri

202 technology for nucleic acids amplifications, polymerase chain reaction (PCR), is significantly limite

203 , and implant inflammation were evaluated by polymerase chain reaction (PCR), microcomputed tomograph

204 DNA-based techniques such as polymerase chain reaction (PCR), real time PCR (RT-PCR)

205 d blood leukocytes was used for quantitative polymerase chain reaction (PCR), RNA sequencing, and com

206 d as AmpSeq-SSR, which combines multiplexing polymerase chain reaction (PCR), targeted deep sequencin

207 atically improved by use of real-time immuno-polymerase chain reaction (PCR), to parasitemia limits o

208 pots defined based on parasite prevalence by polymerase chain reaction (PCR)- and the prevalence of a

209 er-based) cell counters, flow cytometry, and polymerase chain reaction (PCR)-based methods for identi

210 more widely used, we explored the extent of polymerase chain reaction (PCR)-based RSV testing and it

211 The majority of surviving mice remained polymerase chain reaction (PCR)-MRD negative after treat

212 study and had collected a lesional swab for polymerase chain reaction (PCR).

213 s were tested for Cryptosporidium species by polymerase chain reaction (PCR).

214 magnetic microparticles are transferred to a polymerase chain reaction (PCR).

215 nity controls were tested using quantitative polymerase chain reaction (PCR).

216 tomatic adults, were influenza C-positive by polymerase chain reaction (PCR).

217 e tested for HSV-2 and Treponema pallidum by polymerase chain reaction (PCR).

218 ients with HCoV detected in nasal samples by polymerase chain reaction (PCR).

219 leic acid in plasma by NGMS and quantitative polymerase chain reaction (PCR).

220 asured by quantitative reverse transcription polymerase chain reaction (PCR).

221 asites by quantitative reverse transcription polymerase chain reaction (PCR).

222 ose based on culture and colony-counting and polymerase chain reaction (PCR).

223 ve lung aspirate or pleural fluid culture or polymerase chain reaction [PCR]) compared to "RSV pneumo

224 Using a quantitative reverse transcription polymerase chain reaction platform, we analyzed miRNA ex

225 equencing of the AH cfDNA and tumor DNA with polymerase chain reaction primers targeting RB1 gene c.1

226 d for gene expression (reverse transcription polymerase chain reaction), protein expression (immunohi

227 nes and tissues was analyzed by quantitative polymerase chain reaction, protein levels were analyzed

228 e also measured using quantitative real-time polymerase chain reaction (Q-RT-PCR).

229 Microarray and quantitative polymerase chain reaction (qPCR) analyses of Mkx(-/-) PD

230 RNA gene region as the existing quantitative polymerase chain reaction (qPCR) assays of U.S. Environm

231 mplification and then real time quantitative polymerase chain reaction (qPCR) for 21 candidate genes.

232 urements (acetylene block), and quantitative polymerase chain reaction (qPCR) of functional genes in

233 he future of portable real-time quantitative polymerase chain reaction (qPCR) sensors.

234 r, including culture, quantitative real-time polymerase chain reaction (qPCR), and whole-genome seque

235 Oligo Microarrays and quantitative real-time polymerase chain reaction (qPCR), relevant genes express

236 ffectiveness study as well as a quantitative polymerase chain reaction (qPCR)-based etiology study at

237 Quantitative reverse transcription polymerase chain reaction (qRT-PCR) amplification of miR

238 array and quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis.

239 ence morphology using quantitative real-time polymerase chain reaction (qRT-PCR) and RNA in situ hybr

240 les and a quantitative reverse transcription polymerase chain reaction (qRT-PCR) array on 156 samples

241 marily on quantitative reverse transcription-polymerase chain reaction (qRT-PCR), a sensitive method

242 on method-quantitative reverse transcription-polymerase chain reaction (qRT-PCR).

243 Polymerase chain reaction results performed in adults du

244 Real-time polymerase chain reaction revealed the downregulation of

245 ed in contacts, as probable if the identical polymerase chain reaction ribotype was identified in ind

246 10(-5), comparable to real-time quantitative polymerase chain reaction (RQ-PCR)-based MRD detection v

247 was confirmed by urine reverse-transcription polymerase chain reaction (RT-PCR) analysis in 17 cases

248 neural tissue and used reverse-transcription polymerase chain reaction (RT-PCR) and in situ hybridiza

249 Reverse transcription polymerase chain reaction (RT-PCR) experiments showed th

250 urines were tested by qualitative real-time polymerase chain reaction (RT-PCR) for CMV DNA with quan

251 testing by singleplex reverse-transcription polymerase chain reaction (RT-PCR) for laboratory-confir

252 ing T. cruzi parasites measured by real time polymerase chain reaction (RT-PCR) in asymptomatic Chaga

253 sting was negative and reverse-transcription polymerase chain reaction (RT-PCR) testing was not perfo

254 analysis and real-time reverse transcription-polymerase chain reaction (RT-PCR) to analyse the effect

255 luorescence, real-time reverse-transcription polymerase chain reaction (RT-PCR), and quantitative RT-

256 sing culture, slide agglutination, real-time polymerase chain reaction (rt-PCR), and whole genome seq

257 utive children aged <18 years with real-time polymerase chain reaction (RT-PCR)-confirmed EVD were en

258 Using quantitative real-time polymerase chain reaction (RT-PCR)and in situ hybridizat

259 everse transcription- quantitative real-time polymerase chain reaction (RT-qPCR) assays and a thoroug

260 3 (FCGR3) genes using real-time quantitative polymerase chain reaction (RT-qPCR) assays in Gabonese c

261 array and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) platforms for fold c

262 to analyze miRNAs by quantitative real-time polymerase chain reaction (RT-qPCR).

263 ccine efficacy against reverse-transcriptase polymerase-chain-reaction (RT-PCR)-confirmed, protocol-d

264 dex, fluorescence in situ hybridization, and polymerase chain reaction screening for relevant abnorma

265 Polymerase chain reaction screening of T. cruzi-infected

266 Variants characterization was performed by polymerase chain reaction sequencing and samples classif

267 ed with azithromycin 1.5g using quantitative polymerase chain reaction specific for M. genitalium DNA

268 rdium for quantitative reverse transcription polymerase chain reaction studies.

269 official methods (i.e. light microscopy and Polymerase Chain Reaction) suggest exploring new analyti

270 tomic data followed by reverse transcriptase-polymerase chain reaction suggested that PSS1 is coregul

271 ral Zanzibar, and were analyzed by real-time polymerase chain reaction targeting multiple pathogens.

272 les were profiled by 16S ribosomal RNA-based polymerase chain reaction-temporal temperature gradient

273 was performed using a commercially available polymerase chain reaction test for 11 periodontal pathog

274 t clinicians should consider IgM antibody or polymerase chain reaction testing for Zika virus as well

275 Polymerase chain reaction testing of ocular fluid is use

276 itis cases were confirmed by biochemical and polymerase chain reaction testing.

277 olation and subsequent reverse transcription polymerase chain reaction, the expression levels of secr

278 m tumor tissues and analyzed by quantitative polymerase chain reaction to detect mutations in KRAS.

279 We performed multiplexed droplet digital polymerase chain reaction to detect spontaneous Kras mut

280 collected and analyzed by means of real-time polymerase chain reaction to determine the presence of v

281 We used immunoblot and quantitative polymerase chain reaction to evaluate the molecular resp

282 al resistance move from targeted culture and polymerase chain reaction to high throughput metagenomic

283 We used real-time polymerase chain reaction to test nasopharyngeal aspirat

284 alyzed by reverse transcription-quantitative polymerase chain reaction, to check for concordance with

285 e problems, we have developed T oligo-primed polymerase chain reaction (TOP-PCR) for full-length nons

286 from plasma and quantified by a quantitative polymerase chain reaction using human telomerase reverse

287 sion profiles were generated by quantitative polymerase chain reaction using RNA extracted from bronc

288 Quantitative polymerase chain reaction was performed on the tissue sp

289 Polymerase chain reaction was used to detect presence of

290 In this study, BRAF(V600E) allele-specific polymerase chain reaction was used to map the neoplastic

291 Quantitative polymerase chain reaction was used to measure expression

292 sessed by quantitative reverse transcription-polymerase chain reaction, was higher in subepicardium v

293 METHODS AND By reverse transcription polymerase chain reaction, we evaluated gene expression

294 genome sequencing and quantitative real-time polymerase chain reaction were performed on longitudinal

295 scopy and quantitative reverse transcription polymerase chain reactions were used to establish the in

296 Quantitative reverse transcriptase-polymerase chain reaction, Western blot, and immunohisto

297 y histology, real-time reverse transcription polymerase chain reaction, Western blotting, and zymogra

298 nalysis was inspired by that in quantitative polymerase chain reactions, where the delay in the ampli

299 by quantification using digital quantitative polymerase chain reaction with an independent cohort of

300 We used 16S rRNA gene polymerase chain reaction with degenerate primers, follo